Tips & Tricks for Data Management in Phoenix WinNonlin
Learn some tips & tricks for the Data Wizard, a data management tool in Phoenix,…
Certara2022 年 11 月 18 日
Tips to Use Phoenix WinNonlin More Efficiently
Certara’s Phoenix™ Pharmacokinetic and Pharmacodynamic (PK/PD) Platform is the single, interoperable hub for sharing pre-clinical…
Certara2022 年 11 月 7 日
Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase
Arsenal will acquire approximately 30M shares at $15 per share from funds controlled by EQT…
Certara2022 年 11 月 7 日
The Role of PBPK Modeling & Simulation in Infants & Neonates
Many factors make it challenging to obtain adequate pediatric samples for use in drug development…
Certara2022 年 11 月 4 日
Why you should select your drug formulation before starting clinical studies
药物开发者常急于推进发现流程以进入人体试验。Most are…
Certara2022 年 10 月 28 日
Accelerating Market Access with Data-Driven Payer Engagement
Using data visualizations to improve access to payers. With the switch to more digital environments,…
Certara2022 年 10 月 25 日
Applications of PBPK modelling for regulatory submissions: case studies involving DDIs, transporters and special populations
Over the past two decades, there have been transformative changes in our approach to using…
Certara2022 年 10 月 20 日
Simultaneous FDA & EMA Submissions for Drug Approvals
Is there a better way? The question always breeds critical thinking and often leads to…
Certara2022 年 10 月 19 日
RAPS sponsored webcast: The EU Clinical Trials Regulation – Challenges Drug Developers Faced in the First 6 months
Join us on November 10th for this webcast being held in partnership with RAPS. The…
Certara2022 年 10 月 17 日
PBPK Modeling & Simulation of Therapeutic Oligonucleotides from Bench to Bedside
Next generation therapeutics Oligonucleotide drugs are unique among therapeutic modalities in that they don’t engage…
Certara2022 年 10 月 14 日
